Related Experiment Video
Updated: Jul 17, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Delayed hypercoagulable state in COVID-19 adolescent patient: a case report.
Desdiani Desdiani1,2, Nita Yulianti3, Anindita Basuki4
1Faculty of Medicine Universitas Sultan Ageng Tirtayasa Cilegon Indonesia.
A rare case of a 16-year-old COVID-19 patient developed hypercoagulation and stroke-like symptoms. Early anticoagulant treatment with low-molecular weight heparin (LMWH) helped reduce these severe thrombotic events.
Area of Science:
- Medicine
- Virology
- Cardiology
Background:
- Coronavirus disease 2019 (COVID-19) is a systemic hyperinflammation disease.
- Extrapulmonary manifestations and hypercoagulable states are recognized complications.
- Hypercoagulability presenting as stroke in adolescents with COVID-19 is exceptionally rare.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

